Ironwood Pharmaceuticals IRWD Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's change in other assets?
- Ironwood Pharmaceuticals (IRWD) reported change in other assets of -$6M in Q1 2026.
- How has Ironwood Pharmaceuticals's change in other assets changed year-over-year?
- Ironwood Pharmaceuticals's change in other assets decreased by 1573.5% year-over-year, from $407K to -$6M.
- What is the long-term trend for Ironwood Pharmaceuticals's change in other assets?
- Over 3 years (2021 to 2025), Ironwood Pharmaceuticals's change in other assets has grown at a -15.2% compound annual growth rate (CAGR), from -$601K to -$367K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.